Gastroenterology Doctors in Medford, MA Accepting Medicare

4 Gastroenterology doctors found. Showing 1 - 4

Fehmida A Chipty, M.D. Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 92 High St, Medford, MA 02155 Phone: 781-391-8015    Fax: 781-391-9119

James A. Kemp, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 26 City Hall Mall, Medford, MA 02155 Phone: 781-306-5300    Fax: 781-306-5080

Gale S. Fiarman, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 26 City Hall Mall, Medford, MA 02155 Phone: 617-421-1091    Fax: 781-306-5080

Dr. Zain Kassam, MD, MPH, FRCPC Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 196 Boston Ave, Suite #1000, Medford, MA 02155 Phone: 857-333-7375

News Archive

Large-scale study maps the genetic underpinnings of early TB progression

While the vast majority of the 1.8 billion people infected with the TB bacterium never experience active disease, an estimated 5 to 15 percent do develop full-blown infections-roughly half of them within 18 months of exposure.

Researchers discover human genes that might contribute to ALS

Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is a universally fatal neurodegenerative disease. Mutations in two related proteins, TDP-43 and FUS, cause some forms of ALS. Specifically, these two proteins are RNA-binding proteins that connect to RNA to regulate the translation of proteins and other cellular functions such as RNA splicing and editing. In a new study, researchers at the Perelman School of Medicine at the University of Pennsylvania discovered additional human genes with properties similar to TDP-43 and FUS that might also contribute to ALS.

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Novartis will highlight more than 140 presentations on key data from its extensive oncology portfolio at the leading year-end scientific meetings devoted to hematology and breast cancer, demonstrating continued innovation in research and development efforts to advance the care of patients with cancer and rare diseases.

Liquid biopsies show potential use for cancer screening

A new study has shown the potential of analyzing cell-free DNA (cfDNA) present in patients' blood for cancer markers in early cancer detection. This technique was used in some instances for patients who already were diagnosed with a cancer as reported by some studies.

PET images of microglial activation levels could better predict Alzheimer's disease progression

Researchers have discovered a way to better predict progression of Alzheimer's disease. By imaging microglial activation levels with positron emission tomography, researchers were able to better predict progression of the disease than with beta-amyloid PET imaging, according to a study published in the April issue of the Journal of Nuclear Medicine.

Read more Medical News

› Verified 9 days ago